FDA scientists warn that some popular peptides are ineffective and potentially dangerous.

Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. The vast majority of pancreatic cancer patients experience recurrence even after surgery. An ...

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, ...

IO Biotech announced promising findings regarding a novel peptide vaccine designed to counter the immunosuppressive effects of Transforming Growth Factor Beta (TGF-β) in solid tumors. The research, ...

A phase Ib study of a pooled synthetic long peptide mutant KRAS vaccine combined with balstilimab/botensilimab in metastatic pancreatic cancer and metastatic MMR ...

Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted T-cell responses. A peptide-peptide conjugate technology previously developed by researchers ...

GLSI-100 has received FDA fast track designation for HLA-A*02-positive and HER2-positive breast cancer, expediting its development and review process. Preliminary data from the FLAMINGO-01 trial shows ...

Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know ...

The vast majority of pancreatic cancer patients experience recurrence even after surgery. An experimental vaccine could change that, an early-phase study found. The vaccine is based on peptides, ...